Helmerhorst FM - Search Results

1

Risk of venous thrombosis with hormone-replacement therapy.

Vandenbroucke JP, Helmerhorst FM. Vandenbroucke JP, et al. Among authors: helmerhorst fm. Lancet. 1996 Oct 12;348(9033):972. doi: 10.1016/S0140-6736(05)64918-5. Lancet. 1996. PMID: 8855846 No abstract available.

2

[Oral contraception increases the chance of venous thrombosis in factor V Leiden mutation].

Vandenbroucke JP, Briët E, Helmerhorst F, van der Meer FJ. Vandenbroucke JP, et al. Ned Tijdschr Geneeskd. 1995 May 27;139(21):1067-71. Ned Tijdschr Geneeskd. 1995. PMID: 7783798 Review. Dutch. No abstract available.

3

Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.

Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Büller HR, Vandenbroucke JP. Bloemenkamp KW, et al. Among authors: helmerhorst fm. Lancet. 1995 Dec 16;346(8990):1593-6. doi: 10.1016/s0140-6736(95)91929-5. Lancet. 1995. PMID: 7500751

4

Mortality from venous thromboembolism and myocardial infarction in young women in the Netherlands.

Vandenbroucke JP, Bloemenkamp KW, Helmerhorst FM, Rosendaal FR. Vandenbroucke JP, et al. Among authors: helmerhorst fm. Lancet. 1996 Aug 10;348(9024):401-2. doi: 10.1016/s0140-6736(96)24032-2. Lancet. 1996. PMID: 8709744 No abstract available.

5

Third-generation oral contraceptives and venous thrombosis.

Vandenbroucke JP, Helmerhorst FM, Bloemenkamp KW, Rosendaal FR. Vandenbroucke JP, et al. Among authors: helmerhorst fm. Lancet. 1997 Mar 8;349(9053):731; author reply 732-3. doi: 10.1016/S0140-6736(05)60172-9. Lancet. 1997. PMID: 9078225 Free article. No abstract available.

6

Oral contraceptives and thrombotic disease: risk of venous thromboembolism.

Helmerhorst FM, Bloemenkamp KW, Rosendaal FR, Vandenbroucke JP. Helmerhorst FM, et al. Thromb Haemost. 1997 Jul;78(1):327-33. Thromb Haemost. 1997. PMID: 9198174 Free article. Review.

7

Third-generation oral contraceptive and deep venous thrombosis: from epidemiologic controversy to new insight in coagulation.

Vandenbroucke JP, Helmerhorst FM, Bloemenkamp KW, Rosendaal FR. Vandenbroucke JP, et al. Among authors: helmerhorst fm. Am J Obstet Gynecol. 1997 Oct;177(4):887-91. doi: 10.1016/s0002-9378(97)70289-8. Am J Obstet Gynecol. 1997. PMID: 9369840 Review.

8

The pill and venous thromboembolism: a disarray of several layers of debate.

Helmerhorst FM, Rosendaal FR, Vandenbroucke JP. Helmerhorst FM, et al. Hum Reprod. 1998 May;13(5):1119-20. doi: 10.1093/oxfordjournals.humrep.a019702. Hum Reprod. 1998. PMID: 9647526 No abstract available.

9

Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.

Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Koster T, Bertina RM, Vandenbroucke JP. Bloemenkamp KW, et al. Among authors: helmerhorst fm. Thromb Haemost. 1998 Sep;80(3):382-7. Thromb Haemost. 1998. PMID: 9759614

10

Venous thromboembolism and the pill. The WHO technical report on cardiovascular disease and steroid hormone contraception: state-of-the-art. World Health Organization.

Helmerhorst FM, Rosendaal FR, Vandenbroucke JP. Helmerhorst FM, et al. Hum Reprod. 1998 Nov;13(11):2981-3. doi: 10.1093/humrep/13.11.2981. Hum Reprod. 1998. PMID: 9853839 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

239 results

Search Page